AVITA Medical (RCEL) Free Cash Flow (2019 - 2025)
AVITA Medical filings provide 7 years of Free Cash Flow readings, the most recent being -$4.4 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 43.59% to -$4.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$31.8 million, a 35.11% increase, with the full-year FY2025 number at -$31.8 million, up 35.11% from a year prior.
- Free Cash Flow hit -$4.4 million in Q4 2025 for AVITA Medical, up from -$6.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$639000.0 in Q3 2021 to a low of -$22.0 million in Q1 2024.
- Median Free Cash Flow over the past 5 years was -$9.4 million (2023), compared with a mean of -$9.1 million.
- Biggest five-year swings in Free Cash Flow: soared 91.77% in 2021 and later tumbled 248.4% in 2023.
- AVITA Medical's Free Cash Flow stood at -$639000.0 in 2021, then crashed by 383.1% to -$3.1 million in 2022, then tumbled by 248.4% to -$10.8 million in 2023, then increased by 27.58% to -$7.8 million in 2024, then surged by 43.59% to -$4.4 million in 2025.
- The last three reported values for Free Cash Flow were -$4.4 million (Q4 2025), -$6.7 million (Q3 2025), and -$10.2 million (Q2 2025) per Business Quant data.